** Shares of medical product maker Bioventus BVS.O soar 23.5% to $10.82

** Q4 total revenue rises 13.5% to $153.6 million from a year ago, beating analysts' estimate of $145.2 million - data compiled by LSEG

** Co reports quarterly adjusted EPS of 15 cents per share vs estimate of 8 cents per share

** Including session's move, stock is up 1.4% YTD

(Reporting by Jaiveer Singh Shekhawat in Bengaluru)

((JaiveerSingh.Shekhawat@thomsonreuters.com;))